Arix Bioscience Plc Company Secretary Change (6350C)

TIDMARIX

RNS Number : 6350C

Arix Bioscience Plc

24 February 2022

24 February 2022

Arix Bioscience plc

Appointment of Company Secretary

Arix Bioscience plc ("Arix" or the "Company") a global venture capital company focused on investing in and building breakthrough biotech companies, today announces the appointment of Derringtons Limited as Company Secretary with immediate effect. Derringtons will take over the role from the company's CEO and General Counsel, Robert Lyne, who consequently will relinquish his additional responsibilities as Company Secretary to focus on the core operations of the business.

Derringtons are a team of qualified Company Secretaries, with over 30 years of combined experience who deliver professional company secretarial services and provide independent governance advice to both private and listed companies and who have extensive experience in supporting listed investment trusts and operating companies.

Ends.

For further information please contact:

Derringtons Limited, Company Secretary

[phone]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

COSSEFESDEESELE

(END) Dow Jones Newswires

February 24, 2022 03:00 ET (08:00 GMT)